Cargando…

Correction: Functional abnormalities in induced Pluripotent Stem Cell-derived cardiomyocytes generated from titin-mutated patients with dilated cardiomyopathy

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2018
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6224169/ https://www.ncbi.nlm.nih.gov/pubmed/30408120 http://dx.doi.org/10.1371/journal.pone.0207548

Ejemplares similares

Functional abnormalities in induced Pluripotent Stem Cell-derived cardiomyocytes generated from titin-mutated patients with dilated cardiomyopathy
por: Schick, Revital, et al.
Publicado: (2018)

Publisher Correction: Relevance of Titin Missense and Non-Frameshifting Insertions/Deletions Variants in Dilated Cardiomyopathy
por: Akinrinade, Oyediran, et al.
Publicado: (2020)

Circular RNA Expression for Dilated Cardiomyopathy in Hearts and Pluripotent Stem Cell–Derived Cardiomyocytes
por: Zhang, Yiyu, et al.
Publicado: (2021)

Role of Titin Missense Variants in Dilated Cardiomyopathy
por: Begay, Rene L., et al.
Publicado: (2015)

Investigating LMNA-Related Dilated Cardiomyopathy Using Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes
por: Shemer, Yuval, et al.
Publicado: (2021)

Titin: a phenotype-genotype descriptive comparison of dilated cardiomyopathy
por: Baksi, Arun J, et al.
Publicado: (2014)

Genetic epidemiology of titin-truncating variants in the etiology of dilated cardiomyopathy
por: Tabish, Ali M., et al.
Publicado: (2017)

Correction: Identification and Characterization of Calcium Sparks in Cardiomyocytes Derived from Human Induced Pluripotent Stem Cells
por: Zhang, Guang Qin, et al.
Publicado: (2013)

The first titin (c.59926 + 1G > A) founder mutation associated with dilated cardiomyopathy
por: Hoorntje, Edgar T., et al.
Publicado: (2017)

Depletion of m(6)A reader protein YTHDC1 induces dilated cardiomyopathy by abnormal splicing of Titin
por: Gao, Siyun, et al.
Publicado: (2021)

Titin Truncating Variants in Dilated Cardiomyopathy – Prevalence and Genotype-Phenotype Correlations
por: Franaszczyk, Maria, et al.
Publicado: (2017)

Correction: Cardiomyocyte-Specific Ablation of Med1 Subunit of the Mediator Complex Causes Lethal Dilated Cardiomyopathy in Mice
por: Jia, Yuzhi, et al.
Publicado: (2016)

Correction: Calreticulin Induces Dilated Cardiomyopathy
por: Lee, Dukgyu, et al.
Publicado: (2013)

Correction: Hydrogen Sulfide Suppresses Outward Rectifier Potassium Currents in Human Pluripotent Stem Cell-Derived Cardiomyocytes
por: Wei, Heming, et al.
Publicado: (2013)

Correction: Modulation of Serotonin Transporter Function during Fetal Development Causes Dilated Heart Cardiomyopathy and Lifelong Behavioral Abnormalities
por: Noorlander, Cornelle W., et al.
Publicado: (2009)

Trends and Limitations in the Assessment of the Contractile Properties of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes From Patients With Dilated Cardiomyopathy
por: Ito, Masamichi, et al.
Publicado: (2020)

Relevance of Titin Missense and Non-Frameshifting Insertions/Deletions Variants in Dilated Cardiomyopathy
por: Akinrinade, Oyediran, et al.
Publicado: (2019)

Truncating Variants in Titin Independently Predict Early Arrhythmias in Patients With Dilated Cardiomyopathy
por: Tayal, Upasana, et al.
Publicado: (2017)

Correction to: Transplantation of human induced pluripotent stem cell-derived cardiomyocytes improves myocardial function and reverses ventricular remodeling in infarcted rat hearts
por: Guan, Xumin, et al.
Publicado: (2020)

Titin-truncating mutations associated with dilated cardiomyopathy alter length-dependent activation and its modulation via phosphorylation
por: Vikhorev, Petr G, et al.
Publicado: (2020)

Correction: An integrated characterization of contractile, electrophysiological and structural cardiotoxicity of Sophora tonkinensis Gapnep. in human pluripotent stem cell-derived cardiomyocytes
por: Wang, Ruiying, et al.
Publicado: (2023)

Generation of two induced pluripotent stem cell lines from dilated cardiomyopathy patients carrying TTN mutations
por: Zhang, Tina Tianbo, et al.
Publicado: (2022)

Human Induced Pluripotent Stem-Cell-Derived Cardiomyocytes as Models for Genetic Cardiomyopathies
por: Brodehl, Andreas, et al.
Publicado: (2019)

Antisense-mediated exon skipping: a therapeutic strategy for titin-based dilated cardiomyopathy
por: Gramlich, Michael, et al.
Publicado: (2015)

Dysregulated IER3 Expression is Associated with Enhanced Apoptosis in Titin-Based Dilated Cardiomyopathy
por: Zhou, Qifeng, et al.
Publicado: (2017)

Titin-Related Dilated Cardiomyopathy: The Clinical Trajectory and the Role of Circulating Biomarkers in the Clinical Assessment
por: Chmielewski, Przemysław, et al.
Publicado: (2021)

Author Correction: Abnormal contractility in human heart myofibrils from patients with dilated cardiomyopathy due to mutations in TTN and contractile protein genes
por: Vikhorev, Petr G., et al.
Publicado: (2018)

Correction: Evaluation of Changes in Morphology and Function of Human Induced Pluripotent Stem Cell Derived Cardiomyocytes (HiPSC-CMs) Cultured on an Aligned-Nanofiber Cardiac Patch
por: Khan, Mahmood, et al.
Publicado: (2015)

Electrophysiological abnormalities in induced pluripotent stem cell‐derived cardiomyocytes generated from Duchenne muscular dystrophy patients
por: Eisen, Binyamin, et al.
Publicado: (2019)

Generation of human induced pluripotent stem cell lines carrying heterozygous PLN mutation from dilated cardiomyopathy patients
por: Caudal, Arianne, et al.
Publicado: (2022)

Correction: Diuretic dose trajectories in dilated cardiomyopathy: prognostic implications
por: Nuzzi, Vincenzo, et al.
Publicado: (2022)

Maturation of Pluripotent Stem Cell-Derived Cardiomyocytes Enables Modeling of Human Hypertrophic Cardiomyopathy
por: Knight, Walter E., et al.
Publicado: (2021)

Modeling hypertrophic cardiomyopathy with human cardiomyocytes derived from induced pluripotent stem cells
por: Li, Jiangtao, et al.
Publicado: (2022)

Tampering with springs: phosphorylation of titin affecting the mechanical function of cardiomyocytes
por: Hamdani, Nazha, et al.
Publicado: (2017)

Publisher Correction: Syngeneic Mesenchymal Stem Cells Reduce Immune Rejection After Induced Pluripotent Stem Cell-Derived Allogeneic Cardiomyocyte Transplantation
por: Yoshida, Shohei, et al.
Publicado: (2020)

Phenotypic recapitulation and correction of desmoglein-2-deficient cardiomyopathy using human-induced pluripotent stem cell-derived cardiomyocytes
por: Shiba, Mikio, et al.
Publicado: (2021)

Generation and Characterization of Functional Cardiomyocytes Derived from Human T Cell-Derived Induced Pluripotent Stem Cells
por: Seki, Tomohisa, et al.
Publicado: (2014)

Phenotype and Clinical Outcomes of Titin Cardiomyopathy
por: Tayal, Upasana, et al.
Publicado: (2017)

Cardiomyopathy phenotypes in human-induced pluripotent stem cell-derived cardiomyocytes—a systematic review
por: Eschenhagen, Thomas, et al.
Publicado: (2018)

Modeling Duchenne Muscular Dystrophy Cardiomyopathy with Patients’ Induced Pluripotent Stem-Cell-Derived Cardiomyocytes
por: Eisen, Binyamin, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ifn4frpl1u3ro8llul10a9pc48